Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X

2 years ago

CHICAGO, IL / ACCESSWIRE / December 20, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

FendX Technologies Announces Non-Brokered Private Placement with Strategic Investors

2 years ago

Oakville, Ontario--(Newsfile Corp. - December 20, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or…

National Minority Quality Forum Announces Published Results of Baseline Minority and Rural Coronavirus Insights Study in Population Health Management

2 years ago

Study finds that despite past headlines, COVID-19 infection rates are higher amongst people of color.Washington, D.C.--(Newsfile Corp. - December 20,…

TravelNurseSource Announces Spring Scholarship Winner

2 years ago

LANCASTER, PA / ACCESSWIRE / December 20, 2023 / We are thrilled to announce that Stephanie Nwegbu has been chosen…

Tenon Medical Announces Participation in Two Key Immersive Webinar Physician Training Programs Featuring the Company’s Catamaran(R) SI Joint Fusion System

2 years ago

~ Training Programs Led by Dr. Matthew Davies from Duluth, MN and Included Simulated Catamaran Procedure ~~ Reached Approximately 60…

Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study REMOVE with CATUVAB(R) to Eliminate Tumor Cells from Surgical Blood

2 years ago

BERLIN, GERMANY / ACCESSWIRE / December 20, 2023 / Lindis Blood Care, a company aiming to set a new standard…

Leafbuyer Technologies, Inc. Announces Best Sales Month in Company History

2 years ago

Technology Company Records All Time Record Monthly SalesDENVER, CO / ACCESSWIRE / December 20, 2023 / Leafbuyer Technologies, Inc. ("Leafbuyer"…

Success Beyond Startup: Nurturing Growth as a Co-Founder with Kilo Health

2 years ago

VILNIUS, LITHUANIA / ACCESSWIRE / December 20, 2023 / From developing healthcare systems to personalized fitness apps such as Joggo,…

MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials

2 years ago

VANCOUVER, BC / ACCESSWIRE / December 20, 2023 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), Chief Executive Officer…

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset

2 years ago

In the subset of Antibody-Drug Conjugate (ADC) refractory patients, Overall Survival (OS) data of BriaCell’s combination regimen exceeded that of…